November 14, 2025

The Risk Factor Going Unscreened

Adverse childhood experiences drive elevated all-cause mortality across medical conditions, with emergency department patients also showing nearly double the death rates.

Conexiant

November 12, 2025

CDER Taps FDA Veteran as Director 

The HHS and FDA have appointed longtime oncology innovator Richard Pazdur, MD, as director of the Center for Drug Evaluation and Research.

Conexiant

November 12, 2025

Dual Therapy for Coronary Disease: How Safe Is It? 

Adding aspirin to long-term oral anticoagulation in patients with chronic coronary syndrome increased mortality and major bleeding without improving cardiovascular outcomes.

Conexiant

November 12, 2025

Adverse Pregnancy Outcomes Offer Early Clues to Future AF

Researchers found that adverse pregnancy outcomes increase women’s long-term risk of atrial fibrillation.

Conexiant

November 10, 2025

FDA Proposes Removal of Box Warnings

The FDA proposed updates to menopausal hormone therapy labeling to reflect current evidence on benefits and risks.

Conexiant

November 10, 2025

Which Dressing Best Supports Scar Healing?

Researchers compare Dermabond and Steri-Strips performance after breast surgery.

Conexiant

November 05, 2025

Medical Oddities: It Actually Pays To Get Old 

From despair to repair, these studies flip what we thought we knew.

Conexiant

November 05, 2025

Shame in Medicine—A Quiet Epidemic

A new movement in medicine aims to teach “shame competence,” helping physicians recognize and manage one of the field’s most corrosive yet overlooked emotions.

KFF Health News

November 04, 2025

Should SGLT-2 Inhibitors Be Continued After a UTI?

Patients with type 2 diabetes who developed urinary tract infections while taking sodium-glucose cotransporter-2 inhibitors faced higher heart and kidney risks.

Conexiant